Shane Ward - 27 Mar 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: COO & CLO
Signature: /s/ Shane Ward
Issuer symbol: CDTX
Transactions as of: 27 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 29 Mar 2023, 17:32:15 UTC
Previous filing: 13 Mar 2023
Next filing: 12 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+126,667	+150%	$0.000000	211,243	27 Mar 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+253,333		$0.000000	253,333	27 Mar 2023	Common Stock	253,333	$1.01	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 27, 2023. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2024, 2025, and 2026, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 27, 2023.